Yfirlit yfir samninga eftir útboð, verðfyrirspurnir og samningskaup. Gildistími frá 1. janúar 2017 Orra
|
|
|
- Grant Burns
- 5 years ago
- Views:
Transcription
1 ATC - flokkur Yfirlit yfir samninga eftir útboð, verðfyrirspurnir og samningskaup. Gildistími frá 1. janúar 2017 NVN Orra númer Heiti lyfs Gildistími samnings B05XA Addex-Magnesium B05AA Albuman B05AA Albuman B05AA Albuman B05AA Albuman L01BA Alimta L01BA Alimta J01CR Amoksiklav J01CR Amoksiklav J01CR Amoksiklav J01CA Amoxicillin Mylan J01CA Amoxicillin Mylan J01CA Amoxicillin Mylan L01XX Amsalyo L01BC Arabine B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp B03XA Aranesp L04AA Aubagio J01CR Augmentin L01XC Avastin L01XC Avastin L03AB Avonex L03AB Avonex J01FA Azithromycin Actavis J01FA Azithromycin Actavis J01FA Azithromycin Eberth L01XX BCG medac L01AA Bendamustine Accord B02BD Benefix B02BD Benefix L04AA Benlysta L04AA Benlysta J01CE Benzylpenicillin Panpharma J01CE Benzylpenicillin Panpharma
2 J01CE Benzylpenicillin Panpharma L01AD BICNU (CARMUSTINE FOR INJECTION) L01XE Ekki til Bosulif L01XE Ekki til Bosulif M03AX Botox L01XA Carboplatin Actavis J01DD Vantar Cefotaxamin J01DC Cefuroxime Villerton FarmaPlus J01DC Cefuroxime Villerton FarmaPlus B06AC Cinryze J01MA Ciprofloxacillin "Villerton" J01MA Ciprofloxacillin "Villerton" J01MA Ciprofloxacin Portfarma J01MA Ciprofloxacin Portfarma L01XA Cisplatin L01XA Cisplatin Strides A06AB CitraFleet J01CF Cloxacillin Villerton B02BD Cofact L03AX Ekki til Copaxone J05AB Copegus J05AB Copegus L04AC Cosentyx L01XE Ekki til Cotellic L01AX Dacarbazine L01AX Dacarbazine J01FF Dalacin J01FF Dalacin J01FF Dalacin J01FF Dalacin H02AB Deltison H02AB Depo-Medrol H02AB Depo-Medrol H02AB Depo-Medrol H02AB Depo-Medrol N05CM Dexdor N05CM Dexdor N05CM Dexdor N05CM Dexdor J02AC Diflucan L01CD Docetaxel Kabi 160mg / 8 ml J01AA Doxylin J01AA Doxylin N02AB Durogesic J02AX Ecalta C03CC EDECRIN C03CC EDECRIN L04AB Enbrel L04AB Enbrel L04AB Enbrel
3 L04AB Enbrel L01DB Epirubicin Actavis L01XC Erbitux M03AC Esmeron A02BC Esomeprazole Alvogen L01CB Eto Gry L01CB Etopocid Fresenius S01LA Eylea L02BA Faslodex N02AB Fentanyl Actavis N02AB Fentanyl Actavis N02AB Fentanyl Actavis N02AB Fentanyl Actavis B03AC Ferinject B03AC Ferinject J01XD Flagyl J02AC Fluconazole Portfarma J02AC Fluconazole Portfarma J02AC Fluconazole Portfarma J02AC Fluconazole Portfarma J02AC Fluconazole Portfarma L01BB Fludara V08CA Gadovist L01BC Gemcitabine Hospira H01AC Genotropin H01AC Genotropin J01GB Gentafleece 12x8 cm J01GB Ekki til Gentafleece 20x5 cm J01GB Gentafleece 6x4 cm J01GB Gentamicin B. Braun J01GB Gentamicin B. Braun J01GB Gentamicin B. Braun L04AA Gilenya B05BB Glucos 100 mg/ml með Na40+K B05BA Glucos Baxter Viaflo B05BA Glucos Baxter Viaflo B05BA Glucos Baxter Viaflo B05BA Glucos Baxter Viaflo B05BA Glucos Baxter Viaflo B05BA Glucos Baxter Viaflo B05BA Glucose B05BA Glucose B05BA Glucose B05BA Glucose H01BA Glypressin B02BD Helixate Nexgen B02BD Helixate Nexgen B02BD Helixate Nexgen L01XC Herceptin L01XC Herceptin
4 L01AA Holoxan H01AC Humatrope H01AC Humatrope H01AC Humatrope N02AA Hydromorphone Hydrochloride USP M05BA Iasibon M05BA Ibandronic acid Portfarma L01XE Imatinib Accord L01XE Imatinib Accord L01XE IMBRUVICA L01XE IMBRUVICA L04AB Inflectra L01XE INLYTA L01XE INLYTA L01XE Iressa L01XX Irinotecan Hospira V03AF Isovorin V03AF Isovorin V03AF Isovorin Ekki skilgreint Istodax L01CD Jevtana B05BA Kabiven B05BA Kabiven B05BA Kabiven B05BA Kabiven B05BA Kabiven Perifer B05BA Kabiven Perifer B05BA Kabiven Perifer L01XC Kadcyla L01XC Kadcyla B05BB Kalium-Natrium-Glucos L01XC KEYTRUDA J06BA Kiovig J06BA Kiovig J06BA Kiovig J06BA Kiovig J06BA Kiovig J06BA Kiovig B01AB Klexane B01AB Klexane B01AB Klexane B01AB Klexane B01AB Klexane B01AB Klexane A06AG Klyx A02BC Lanzo N01BB Lidokain Mylan N01BB Lidokain Mylan L03AA Lonquex L01XX Lynparza
5 L01XC MabThera L01XC MabThera L01XC MabThera V08CA Magnevist V08CA Magnevist V08CA Magnevist V08CA Magnevist L01XE Mekinist J01DH Meropenem Mylan "Ebert" J01DH Meropenem Mylan "Ebert" L01BA Methotrexate Pfizer L01BA Methotrexate Pfizer L01BA Methotrexate Pfizer L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01BA Metoject L01CB Mito Medac B03AC Monofer B03AC Monofer B03AC Monofer B03AC Monofer N02AA Morphine Sulphate BP J02AX Mycamine J02AX Mycamine L01XE Mylaukim L01XE Mylaukim J06BA Nanogam J06BA Nanogam J06BA Nanogam J06BA Nanogam B05BB Natriumklorid B05BB Natriumklorid B05BB Natriumklorid B05BB Natriumklorid Skolvökvi Natriumklorid Skolvökvi Natriumklorid Skolvökvi Natriumklorid V07AB Natriumklorid V07AB Natriumklorid V07AB Natriumklorid V07AB Natriumklorid B05CB Natriumklorid B05BB Natriumklorid Baxter Viaflo
6 B05BB Natriumklorid Baxter Viaflo B05BB Natriumklorid Baxter Viaflo B05BB Natriumklorid Baxter Viaflo B03XA NeoRecormon B03XA NeoRecormon B03XA NeoRecormon B03XA NeoRecormon B03XA NeoRecormon B03XA NeoRecormon B03XA NeoRecormon L03AA Neulasta A02BC Nexium A02BC Nexium A02BC Omeprazol Actavis A02BC Omeprazol Actavis A02BC Omeprazol Actavis V08AB Omnipaque V08AB Omnipaque V08AB Omnipaque V08AB Omnipaque V08AB Omnipaque V08AB Omnipaque V08AB Omnipaque V08CA Omniscan V08CA Omniscan V08CA Omniscan V08CA Omniscan V08CA Omniscan V08CA Omniscan H01AC Omnitrope H01AC Omnitrope H01AC Omnitrope C02KX Vantar Opsumit L04AA Orencia M05BA Ostacid L01CD Paclitaxel Actavis M05BA Pamidronatdinatrium Hospira M05BA Pamidronatdinatrium Hospira M05BA Pamidronatdinatrium Hospira M05BA Pamidronatdinatrium Hospira N02BE PANODIL B05XA Peditrace J01CA Penomax N01AF Pentocur N01AF Pentocur L01XC Perjeta J01CR Piperacillin Tazobactam "Reig Jofre" B05BB Plasmalyte B05BB Plasmalyte B05BB Plasmalyte Glucos
7 B05BB Plasmalyte Glucos L03AB Plegridy L03AB Plegridy L03AB Plegridy L03AB Plegridy B01AE Pradaxa B01AE Pradaxa B01AE Pradaxa B01AE Pradaxa B01AE Pradaxa B01AE Pradaxa H02AB Prednisolone Actavis H02AB Prednisolone Actavis J06BA Privigen J06BA Privigen J06BA Privigen J06BA Privigen J06BA Privigen A16AA Procysbi N01AX Propolipid 1% N01AX Propolipid 1% N01AX Propolipid 1% N01AX Propolipid 2% RO5CB Pulmozyme B01AD Rapilysin N06BX Raxone L03AB Rebif L03AB Rebif L03AB Rebif B02BD ReFacto AF B02BD ReFacto AF B02BD ReFacto AF B02BD ReFacto AF B02BD ReFacto AF L04AB Remicade A16AB Replagal B02BX Revolade B02BX Revolade B02BX Revolade B02BX Revolade B05BB Ringer-acetat B05BB Ringer-acetat L04AC RoActemra L04AC RoActemra L04AC RoActemra L04AC RoActemra J01DD Rocephalin J01DD Rocephalin B06AC Ekki til Ruconest H01AC Saizen
8 H01AC Saizen H01AC Saizen H01AC Saizen L01AA Sendoxan N01AB Sevoflurane Baxter C01CX Simdax L04AB Simponi L04AB Simponi B05DB Sleep Safe Balance B05DB Sleep Safe Balance B05DB Sleep Safe Balance B05BA SmofKabiven B05BA SmofKabiven B05BA SmofKabiven B05BA SmofKabiven B05BA SmofKabiven B05BA SmofKabiven EF B05BA SmofKabiven EF B05BA SmofKabiven Perifer B05BA SmofKabiven Perifer H02AB Solu-Cortef H02AB Solu-Cortef H02AB Solu-Cortef H02AB Solu-Medrol H02AB Solu-Medrol H02AB Solu-Medrol B05XC Soluvit J01CF Staklox J01CF Staklox B05DB Stay Safe Balance B05DB Stay Safe Balance B05DB Stay Safe Balance B05DB Stay Safe Balance B05DB Stay Safe Balance B05DB Stay Safe Balance L04AC Stelara L04AC Stelara V07AB Sterilt Vatn V07AB Sterilt Vatn V07AB Sterilt Vatn V07AB Sterilt Vatn V07AB Sterilt Vatn V07AB Sterilt Vatn V07AB Sterilt Vatten N01AB Suprane L01XE Sutent L01XE Sutent L01XE Sutent L01XE Tarceva L01XE Tarceva
9 L01XE Tarceva L01XE Tasigna N07XX Tecfidera N07XX Tecfidera L01AX Temomedac L01AX Temomedac A11DA Tiacur A11DA Tiacur B02BC TISSEEL B02BC TISSEEL L01BA Tomudex B05XA Tracel C02KX Tracleer C02KX Tracleer J01AA Tygacil L04AA Tysabri V08AB Ultravist V08AB Ultravist V08AB Ultravist J05AB Valaciclovir Actavis J05AB Valaciclovir Actavis J05AB Valcyte J01XA Vancomycin Actavis J01XA Vancomycin Actavis A07AA Vancomycin Xellia J01XA Vancomycin Xellia L01XC Ekki til Vectibix B03AC Venofer L01CB Vepesid J02AC Vfend J02AC Vfend J02AC Vfend J02AC Vfend L01CA Vincristine Hospira L01CA Vinorelbin Actavis V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque V08AB Visipaque B05XC Vitalipid adult B05XC Vitalipid infant C02KX Volibris C02KX Volibris L01XX Vortemyel
10 L01XE Votrient L01XE Xalkori L01XE Xalkori B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto B01AF Xarelto L01BC Xeloda L01BC Xeloda M03AX Xeomin N05AX Xeplion N05AX Xeplion N05AX Xeplion N05AX Xeplion R03DX Xolair L02BB Xtandi L01XC Yervoy L01XC Yervoy L03AA Zarzio L03AA Zarzio L01DB Zavedos L01DB Zavedos L01XE Zelboraf J01FA Zitromax J01FA Zitromax M05BA Zoledronic Acid Accord M05BA Zoledronic Acid Hospira M05BA Zoledronic Acid Hospira N05CF Ekki til Zopiklon Mylan N05CF Zovand L02BX Zytiga J01XX Zyvoxid J01XX Zyvoxid
Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008
Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008 Authors: Maggie Heginbothom Robin Howe Version: 1 Antibacterial PPS Ysbyty Gwynedd Date: 29/05/2009
Report on the Point Prevalence Survey of Antimicrobial Prescribing in Secondary Care in Wales November/December 2009
Report on the Point Prevalence Survey of Antimicrobial Prescribing in Secondary Care in Wales November/December 2009 Authors: Maggie Heginbothom Robin Howe Version: 1 Antimicrobial PPS - Wales Date: 26/04/2010
Antibacterial Usage in Secondary Care in Wales
A Report from Public Health Wales Antimicrobial Resistance Programme Surveillance Unit: Antibacterial Usage in Secondary Care in Wales 25-214 Authors: Maggie Heginbothom & Robin Howe Date: 14/4/215 Status:
Monthly Webinar. Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm. Event number: Audio dial-in (phone):
Monthly Webinar Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm Event number: 849 291 546 Audio dial-in (phone): 01 526 0058 AMS InSight Monthly Webinar: Tuesday 12th December MicroB: Brewing
Surveillance of Antimicrobial Use and Resistance in Northern Ireland, Annual Report, 2017
Surveillance of Antimicrobial Use and Resistance in Northern Ireland, Annual Report, 2017 CONTENTS Contents Executive summary 3 Background 5 Method 7 Antibiotic resistance..................................
- the details, where possible, of the antibiotic products these companies supply or have supplied.
Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal
Tanzania Journal of Health Research Volume 12, Number 3, July 2010
Tanzania Journal of Health Research Volume 12, Number 3, July 2010 SHORT COMMUNICATION Assessment of antibacterial sale by using the Anatomic Therapeutic Chemical classification and Defined Daily Dose
I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.
Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act
Prior authorization. Member education. Why do some drugs need review and approval? How do I get approval?
Member education Prior authorization Some drugs need to be reviewed before they re covered by your plan. This review helps make sure they re safe and affordable for you. Why do some drugs need review and
Public policy to reduce antibiotic resistance Prof. Niels Frimodt-Moller
Public Policy to Reduce Antibiotic Resistance Niels Frimodt-Moller, Professor, MD DMSc Head, Antibiotic Research National Center for Antimicrobials and Infection Control Statens Serum Institut Copenhagen,
Swedish strategies and methods to combat antibiotic resistance
Swedish strategies and methods to combat antibiotic resistance Stephan Stenmark MD, PhD, County Medical Officer Västerbotten County Council, Sweden Head of Department for communicable disease control and
Department of Pharmacology, Father Muller Medical College Hospital, Mangalore ,INDIA.
Research Article Comparative Drug Utilization of Antimicrobial Agents in Medical and Respiratory Intensive Care Units of a Tertiary Care Teaching Hospital in South India Bincy Benjamin 1, B Sajeev Kumar
Worrying trends in antibiotic use in French hospitals,
vv v Worrying trends in antibiotic use in French, 2008-2013 C. Dumartin, A-M. Rogues, F. L Hériteau, M. Péfau, X. Bertrand, S. Boussat, H. Sénéchal, M. Giard, A. Ingels, L. Lacavé, L. Mouchot, A. Machut,
Approved Drug Product List - Orange Book Reference Listed Drugs by ANDA Reference Standard List. April 2017 Page 1 of 6
April 2017 Page 1 of 6 DESCRIPTION This list refers to drug products approved under an Abbreviated New Drug Application (ANDA) that FDA has selected as reference standards and the associated reference
A Retrospective Study on Antibiotic Use in Different Clinical Departments of a Teaching Hospital in Zawiya, Libya
Ibnosina J Med BS 13 ARTICLE A Retrospective Study on Antibiotic Use in Different Clinical Departments of a Teaching Hospital in Zawiya, Libya Prakash Katakam, Abdulbaset A. Elfituri, Zaidoon H. Ramadan,
ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio
ANTIBIOTICS Orbit s ANTIBIOTICS Portfolio ANTIBIOTICS Antibiotics (from ancient Greek αντιβιοτικά, antibiotiká), also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention
Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules
KAPL list of products applicable for Institutional/Hospital supplies under Pharmaceuticals Purchase Policy (PPP) issued by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India
An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?
An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca
Products List ANTICANCER. Anastrozole Tablets. 1 mg. Bleomycin Injection. 15 units. Bicalutamide Tablets. 50mg /150mg. Bortezomib for Injection
ANTICANCER Anastrozole Tablets Bleomycin Injection Bicalutamide Tablets Bortezomib for Injection Capecitabine Tablets Carboplatin Injection Cisplatin Injection Cyclophosphamide Injection Cyclophosphamide
21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
How to Measure Antimicrobial Consumption
How to Measure Antimicrobial Consumption Dominique L. Monnet National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark Fluoroquinolone consumption Nordic countries,
Inappropriate Antibiotic Utilization: Outpatient Prescription Review of a Regional Secondary Hospital in Kedah, Malaysia
Journal of Pharmacy Practice and Community Medicine.2017, 3(4):215-219 http://dx.doi.org/10.5530/jppcm.2017.4.62 RESEARCH ARTICLE OPEN ACCESS Inappropriate Antibiotic Utilization: Outpatient Prescription
INJECTION GMP FSC AMPICILLIN SODIUM 500mg/1 g+ SULBACTAM DRY POWDER INJECTION GMP FSC
1 S.NO COMPOSITION DOSAGE FORM PLANT CERTIFICATION DOCUMENTS 1 AZITHROMYCIN 500mg AMOXYCILLIN 250mg/500 mg/1 g+ POTASSIUM 2 CLAVULANIC 50mg/100mg/200mg AMPICILLIN SODIUM 500mg/1 g+ SULBACTAM 3 250mg/0.5g
QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health
YOUR PREFERRED PARTNER IN QUALITY HEALTH CARE For better health Manufacturer of Pharmaceutical Products Eka Pharma 308, Samanvay Zillion, Gotri - Sevasi Road, Opp. Shaishav School, Vadodara-391 101, (Guj.)
Chapter 7: Methods of Calculation for Individualized Drug Dosing
Instant download and all chapter Test Bank for Clinical Calculations With Applications to General and Specialty Areas 7th Edition by Joyce Kee, Sally Marshall Link download full: http://testbankair.com/download/test-bank-for-
3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC
rd 3 party manufacturing PRODUCT LIST Category : ANTI BIOTIC ANTI BIOTIC SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 1 Amikacin Sulphate IP 500mg/2ml DRUG LIQUID INJ. VIAL 2 Amoxicillin 200mg & Clavulanic
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES CONTROL ACT 101 OF 1965 31/5.2/0332 BE-TABS 32/5.2/0670
HSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
Antibiotic prescribing patterns in out-of-hours primary care: A population-based descriptive study
Scandinavian Journal of Primary Health Care, 2014; 32: 200 207 ORIGINAL ARTICLE Antibiotic prescribing patterns in out-of-hours primary care: A population-based descriptive study LINDA HUIBERS, GRETE MOTH,
Telephone Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada. Sitemap
Telephone 613-835-9490 Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada Sitemap 25 mg/kg/ dose ( Max : 500 mg/ dose ) PO twice daily for 10 days is recommended by the Infectious Diseases
Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics
Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics Request details Under the Freedom of Information Act 2000 please could you provide me with the following: 1.
Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix O 3 December 2014 Final version Commissioned
NALC Health Benefit Plan High Option 2017 Prescription Benefits Overview
NALC Health Benefit Plan High Option 2017 Prescription Benefits Overview This booklet is a summary of some of the features of the NALC Health Benefit Plan High Option. Detailed information on the benefits
Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
Medicaid and Child Welfare List of Drugs Requiring Prior Authorization
Medicaid and Child Welfare List of Drugs Requiring Prior Authorization The following is the list of drugs that Sunshine Health s utilization management department must approve prior to the drug being given.
New/Revised Product Name Section Changed Abisart HCT APO-Metformin XR Ciloquin Ear Drops Codapane Xtra Donepezil Sandoz Fabu Sports Oil
/Revised Product Name Section Changed Abisart HCT APO-Metformin XR Ciloquin Ear Drops Codapane Xtra Donepezil Sandoz Fabu Sports Oil Ibiamox Irbesartan/HCTZ RBX Irbesartan/HCTZ-GA Lamivudine RBX MCT Pepdite
EUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
https://www.indiamart.com/healthbiotech/
+91-8079454100 Health Biotech Limited https://www.indiamart.com/healthbiotech/ The top most leading manufacturing company offers best quality range of broad portfolio of finished Pharmaceutical Formulations.
OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials
Clinical Monitoring of Outpatient Parenteral Antimicrobial Therapy (OPAT) and Selected Oral Antimicrobial Agents Adult Inpatient/Ambulatory Clinical Practice Guideline Appendix A. Coordinating an OPAT
Bureau of Laboratory Quality Standards Page 1 of 10
1. Ceftriaxone sodium sterile - Cef-3 Inj. (250-IM) - Cef-3 Inj. (250-IV) - Cef-3 Inj. (500-IM) - Cef-3 Inj. (500-IV) - Cef-3 Inj. (1 g -IM) - Cef-3 Inj. (1 g IV) - Cef-3 Inj. (2 g IV) 2. Ceftazidime pentahydrate
AMR Industry Alliance Antibiotic Discharge Targets
AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICATIONS MEXICO S DE R.L. DE C.V. Agrifen Acetaminophen Chlorpheniramine 40 # Amikacin Generic 500 mg 2ml 2 ampoules #
Agrifen Acetaminophen Chlorpheniramine 40 $10 tabs Amikacin Generic 500 mg 2ml 2 ampoules $11 inyectable Amoxil Amoxicillin 500 mg 12 Caps $20 Amoxil Amoxicillin Generic 500 mg 12 Caps $13 Amoxil Amoxicillin
Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
SIMAGCHEM CORPORATION
SIMAGCHEM CORPORATION Corporation SIMAGCHEM was established in 1996. We are a dynamic and innovative chemical supplier company based in China. In term of our teamwork and EPR -BDL database, we are professional
Received 12 September 2008/Returned for modification 13 January 2009/Accepted 1 March 2009
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2009, p. 2082 2088 Vol. 53, No. 5 0066-4804/09/$08.00 0 doi:10.1128/aac.01214-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Quasiexperimental
UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS
UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS Pharmacy Society of South Africa Conference 2018 Ruth Lancaster Contents 1. Background AMR National Strategic Plan 2. Sources of antimicrobial
PRESCRIBING PATTERNS OF ANTIMICROBIALS IN SURGICAL DEPARTMENTS IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA
IJPSR (2014), Vol. 5, Issue 3 (Research Article) Received on 25 October, 2013; received in revised form, 18 November, 2013; accepted, 13 February, 2014; published 01 March, 2014 PRESCRIBING PATTERNS OF
NALC Health Benefit Plan High Option 2018 Prescription Benefits Overview
NALC Health Benefit Plan High Option 2018 Prescription Benefits Overview This booklet is a summary of some of the features of the NALC Health Benefit Plan High Option. Detailed information on the benefits
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
Routine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
Drug Utilization of Antimicrobial drug in Pediatrics Population in a tertiary care hospital in Erode,Tamilnadu,India
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.3, No.3, pp 1530-1536, July-Sept 2011 Drug Utilization of Antimicrobial drug in Pediatrics Population in a tertiary
Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
SHIJIAZHUANG SHOUYAO TRADING CO.,LTD.
POWDR FOR INJ. No. PRODUCT NAM STRNGTH SP 1 Amoxicillin Sodium for Inj. 0.25g,0.5g,1.0g CP 2 Amoxicillin Potassium for Inj. Sodium/Clavulanate 0.6g,1.2g MAIL:Info@sypetec.com WB:www.sypetec.com BP/ 3 Ampicillin
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
GOBIERNO DE PUERTO RICO Administración de Servicios Médicos de Puerto Rico
1 Acetylcysteine Solution 20% Vial 10ml 2 Acetylcysteine Solution 20% Vial 30ml 3 Activated Charcoal Bottle 4 fl oz or 8 fl oz 4 Adenosine 6mg/2ml Inj Solution Syringe / Vial 2ml 5 Albuterol Sulfate Inhalation
Valbazen Giardia 12 mg/lb Twice a day for two days. Amoxi-Drops, Biomox, Polymox Bacterial infections 5-10 mg/lb Once to twice a day
Dosages for drugs commonly 0.4536 used in treating cats. kg) Dosages of body weight, are given except per pound as noted. ( WARNING: Not be Albendazole Valbazen Giardia 12 mg/lb Twice a day for two days
Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 February 2015
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update effective 1 February 2015 Update New Cumulative Zealand for December 2014, January and February
Absolutely fragilis - A case discussion
Absolutely fragilis - A case discussion Rohma Ghani 1 Giovanni Satta 1 Harriet Hughes 2 James Hatcher 1 1 Imperial College Healthcare NHS Trust 2 UK Anaerobe Reference Unit 64F Kuwaiti national Metastatic
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article THE THIRD-GENERATION CEPHALOSPORIN USE IN A REGIONAL GENERAL HOSPITAL IN INDONESIA Rika Yulia 1, Beatrix Eyleen
ALDEYAB, Mamoon A, et al. Abstract
Article The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings ALDEYAB, Mamoon A, et al.
CONCORD DRUGS LIMITED Hyderabad
CONCORD DRUGS LIMITED Hyderabad Product List (Injectables) Tissue Bio Adhesive Product Name Packing Strength/ Each Ampoule Therapeutic use Iso Amyl 2-Cyano Acrylate Ampoule 0.25, 0.50 and 1.0 ml. Bio-Adhesive
NALC Health Benefit Plan High Option 2016 Prescription Benefits Overview
NALC Health Benefit Plan High Option 2016 Prescription Benefits Overview This booklet is a summary of some of the features of the NALC Health Benefit Plan High Option. Detailed information on the benefits
Clinical Practice Standard
Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:
Childrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
UAB Controlled Substances Program Catalog Numbers by Vendor. Catalog # Brand Name Generic Name Schedule Amount Manufacturer Unit Cost Henry Schein
UAB Controlled Substances Program Catalog Numbers by Vendor Henry Schein Animal Health Henry Schein O55175 Buprenex Buprenorphine.3mg/ml Ampule III 5 count Generic $96.69 charges a $5 fee O54888 Buprenorphine
UAB Controlled Substances Program Catalog Numbers by Vendor. Henry Schein charges a $5 fee for any order under $75
UAB Controlled Substances Program Catalog Numbers by Vendor Henry Schein Animal Health O55175 Buprenex Buprenorphine.3mg/ml Ampule III 5 count Generic $96.69 O54888 Buprenorphine Hydrochloride InjectioBuprenorphine
2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
Compliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
Prescribing Patterns of Antibiotics and Sensitivity Patterns of Microorganisms towards Different Antibiotics in Multidisipinary Health Care Hospital.
ISSN 0976 3333 Available Online at www.ijpba.info. International Journal of Pharmaceutical & Biological Archives 2010; 1(2):115-122 CASE STUDY Prescribing Patterns of Antibiotics and Sensitivity Patterns
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
Anti-infection Agents
Pisutam (Lyo) Lyo for Inj. 2.25g 1 Pisutam (Lyo) Lyo for Inj. 4.5g 1 Pisutam Pow. for Inj. 2.25g 1 Pisutam Pow. for Inj. 4.5g 2 Picillina Pow. for Inj. 2g 2 Picillina Pow. for Inj. 4g 2 Ocillina Pow. for
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.40 WINDHOEK - 18 August 2008 No CONTENTS
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$2.40 WINDHOEK - 18 August 2008 No. 4103 GOVERNMENT NOTICES CONTENTS No. 196 Medicines and Related Substances Control Act, 1965: Registration of certain medicines...
Treatment of Community-Acquired Pneumonia in Adults: Analysis of the National Dispensing Database
Basic & Clinical Pharmacology & Toxicology, 2015, 117, 330 334 Doi: 10.1111/bcpt.12426 Treatment of Community-Acquired Pneumonia in Adults: Analysis of the National Dispensing Database Maria Matuz 1, Julia
COMPLIANCE WITH THIS DOCUMENT IS MANDATORY
COVER SHEET NAME OF DOCUMENT Sepsis Pathway Emergency Department TYPE OF DOCUMENT Procedure DOCUMENT NUMBER ISLHD CLIN PROC 137 DATE OF PUBLICATION October 2016 RISK RATING Medium REVIEW DATE October 2018
PRODUCTS LIST INFECTIOLOGY
PRODUCTS LIST THERAPEUTIC CLASS REF. PRODUCT DESIGNATION CONDITIONNING 1ACIC200 Aciclovir 200mg 500 tabs 2ACIC200 Aciclovir 200mg 500 tabs blister 1ACIC400 Aciclovir 400mg 500 tabs 2ACIC400 Aciclovir 400mg
Determination of Antibiotics Consumption in Buali-Sina Pediatric Hospital, Sari
Iranian Journal of Pharmaceutical Research (214), 13 (3): 995-11 Received: February 213 Accepted: November 213 Copyright 214 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health
Registered Drug Product List:
354 Aguirre Ave. Phase III BF Homes Parañaque City, Metro Manila Philippines +63 2 829 7294/ 826 4902 +63 2 820 4151 Email: info@saharint.com / private_2ii@hotmail.com Antibiotic Line Products: 1 P age
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
Anti-infection Agents
Supecef Pow. for Inj. 0.5g 1 Supecef Pow. for Inj. 1g 1 Cefuroxime Pow. for Inj. 750mg 1 Tatumcef Pow. for Inj 0.5g 2 Tatumcef Pow. for Inj 1g 2 Tatumcef Pow. For Inj. 2g 2 Cefazolin Injection 1g 3 Pisutam
Fundamentals of Pharmacology for Veterinary Technicians Chapter 16
Figure 16-1 Figure 16-2 Hypothalamus Releasing factor Releasing factor Anterior pituitary ACTH signals adrenal cortex to glucocorticoids ACTH signals adrenal cortex to glucocorticoids Glucocorticoids Glucocorticoids
Annual Surveillance Report & Antibiotic Guide
861 LANCET(526238) Annual Surveillance Report & Antibiotic Guide Family Practitioners 217 1 CONTENTS RESPIRATORY TRACT PATHOGENS 2 Viral 2 Bacterial 4 COMMON URINARY TRACT PATHOGENS 6 ANTIBIOTIC GUIDELINES
3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on
The Good Antibiotics: the Good, the Bad and the Ugly John P. Cello, MD Professor of Medicine and Surgery, University of California, San Francisco Most organisms can be readily identified by culture, special
Drug Use Evaluation of Antimicrobials in Healthcare Resource Limited Settings of India
Research Article Drug Use Evaluation of Antimicrobials in Healthcare Resource Limited Settings of India Mohanraj Rathinavelu *1, Suvarchala Satyagama 1, Ramkesava Reddy 2, Yiragamreddy Padmanabha Reddy
Amoxicillin dose for gum infection
Amoxicillin dose for gum infection Learn about Prilosec (Omeprazole) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. 30-9-1990 Amoxicillin
GUIDELINES FOR CERTAIN DRUGS TO BE PRESCRIBED for Registered Midwives Practicing in Newfoundland and Labrador
GUIDELINES FOR CERTAIN DRUGS TO BE PRESCRIBED for Registered Midwives Practicing in Newfoundland and Labrador 15. A midwife may, in accordance with the midwifery scope of practice, guidelines and policies
a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
Assessment of antibiotic prescribing in Latvian general practitioners
Dumpis et al. BMC Family Practice 2013, 14:9 RESEARCH ARTICLE Open Access Assessment of antibiotic prescribing in Latvian general practitioners Uga Dumpis 1,3*,Elīna Dimiņa 1,Mārtiņš Akermanis 3, Edgars
Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India
Human Journals Research Article April 2016 Vol.:6, Issue:1 All rights are reserved by Zarine Khety et al. Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Keywords: Drug
Medicines Medikamente Medicamentos Médicaments
Medicines Medikamente Medicamentos Médicaments 6 7 Anaesthetics 01030 ketamine HCl injection 50 mg/ml 25 vials 10 ml 01010 lidocaine HCl injection 1% 25 vials 50 ml 01015 lidocaine HCI injection 2% 20
Birgitte Borck Høg, Senior Scientific Officer Helle Korsgaard, Senior Scientific Officer Tine Hald, Professor National Food Institute, DTU
Methods and challenges in data and information sharing in the Danish Integrated Surveillance for Antimicrobials and Antimicrobial Resistance system (DANMAP) Birgitte Borck Høg, Senior Scientific Officer
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS FINAL November 29, 2017 Working Group: Joanne Langley (Chair),
Suspected adverse drug reaction. Time to onset, Action with drug outcome A 6136 M, years. headache, stomatitis.
1.1. Fluoroquinolones and, a possible group effect Introduction Fluoroquinolone antibiotics are indicated for treatment of infections caused by fluoroquinolonesensitive bacteria. Indications include acute
Guidelines for Antimicrobial treatment for treatment of confirmed infections adults
Guidelines for Antimicrobial treatment for treatment of confirmed infections adults This guideline gives recommendations for treatment of confirmed infections in adults for children please see the Paediatric
Antibiotic use among children in British Columbia, Canada
Journal of Antimicrobial Chemotherapy (2006) 58, 830 839 doi:10.1093/jac/dkl275 Advance Access publication 18 August 2006 Antibiotic use among children in British Columbia, Canada Fawziah Marra 1,2 *,
Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be
Gastrointestinal Infections Infection Comments First Line Agents Penicillin Allergy History of multiresistant Campylobacter Antibiotics not recommended. Erythromycin 250mg PO 6 Alternative to first N/A